Acorda Therapeutics, Inc.
ACORQ
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -69.05% | -20.13% | 56.88% | 9.27% | -5.08% |
| Total Receivables | -0.02% | 24.75% | -18.47% | -6.17% | -23.35% |
| Inventory | 4.86% | 26.69% | 17.64% | -3.42% | -9.24% |
| Prepaid Expenses | 205.87% | 20.85% | -1.35% | -6.16% | -36.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -71.38% | -54.93% | -60.49% | -66.73% | -27.48% |
| Total Current Assets | -28.84% | -8.92% | 2.84% | -15.17% | -15.36% |
|
|
|||||
| Total Current Assets | -28.84% | -8.92% | 2.84% | -15.17% | -15.36% |
| Net Property, Plant & Equipment | -21.29% | -20.15% | -19.84% | -21.41% | -19.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -92.49% | -92.47% | -9.84% | -9.60% | -9.39% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 146.39% | 783.50% | 677.69% | 527.04% | -67.63% |
| Total Assets | -78.24% | -72.57% | -6.86% | -10.24% | -11.61% |
|
|
|||||
| Total Accounts Payable | 248.00% | 36.33% | 7.17% | -60.10% | -67.45% |
| Total Accrued Expenses | -34.62% | 2.66% | 9.88% | -26.50% | 3.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.76% | 12,050.87% | 8.53% | 16.33% | -82.27% |
| Total Finance Division Other Current Liabilities | -1.39% | -19.10% | 28.95% | 79.86% | 48.65% |
| Total Other Current Liabilities | -1.39% | -19.10% | 28.95% | 79.86% | 48.65% |
| Total Current Liabilities | 544.62% | 500.19% | 10.16% | -26.10% | -24.48% |
|
|
|||||
| Total Current Liabilities | 544.62% | 500.19% | 10.16% | -26.10% | -24.48% |
| Long-Term Debt | -- | -- | -3.54% | -4.76% | -6.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -29.79% | -27.07% | -24.80% | -23.11% | 4.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -53.72% | -61.64% | -8.01% | -1.03% | 36.37% |
| Total Liabilities | -10.27% | -11.75% | -3.21% | -6.78% | 0.46% |
|
|
|||||
| Common Stock & APIC | 0.05% | 0.05% | 0.05% | 0.07% | 0.62% |
| Retained Earnings | -27.64% | -27.01% | -1.67% | -2.22% | -6.51% |
| Treasury Stock & Other | 192.59% | 7,970.00% | -94.56% | 142.00% | 106.72% |
| Total Common Equity | -341.39% | -268.72% | -22.19% | -22.80% | -39.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -341.39% | -268.72% | -22.19% | -22.80% | -39.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -341.39% | -268.72% | -22.19% | -22.80% | -39.66% |
|
|
|||||
